Collaborations & Alliances
Related Searches:
Filter by:
406 - 420 of 1091 results
June 14, 2011
Sartorius Stedim Biotech (SSB) and Südpack Medica AG have signed an exclusive 10-year agreement for the development, manufacture and supply of polymer plastic films for the biopharmaceutical market.
Read More »
June 13, 2011
Kareus Therapeutics SA has entered a broad strategic alliance with Quintiles to progress the development of two of Kareus’ preclinical programs through clinical trials.
Read More »
June 13, 2011
Merck and Hanwha Chemical Corp. have entered into an exclusive global agreement to develop and commercialize HD203, Hanwha’s biosimilar form of Enbrel. Hanwha, through its Bio Business Unit, and Merck, through a subsidiary, will work to develop and commercialize HD203.
Read More »
June 9, 2011
Hovione and Particle Sciences Inc (PSI) have entered a collaboration to combine their technologies in an effort to speed development projects targeting poorly water-soluble drugs.
Read More »
June 7, 2011
Pfenex Inc. has entered into a non-exclusive strategic partnership with SAFC, a unit of the Sigma-Aldrich Corp., under which Pfenex will engineer production strains and processes for SAFC’s contract manufacturing customers.
Read More »
June 6, 2011
Patrys Ltd. has extended its relationship with Laureate Biopharmaceutical Services, Inc., to manufacture its lead product PAT-LM1 for preclinical and clinical use.
Read More »
June 6, 2011
Evotec AG has entered into a medicinal chemistry collaboration with Active Biotech AB, following the successful conclusion of a High Throughput Screening campaign to identify small molecule modulators of Active Biotech’s priority biological target involved in immune disorders and cancer.
Read More »
June 6, 2011
Elite Pharmaceuticals, Inc. has entered into a commercial manufacturing and supply agreement with Mikah Pharma, LLC. Elite will perform the lab stability studies, manufacturing and packaging for two generic products, Isradipine Capsules USP, and Phendimetrazine Tartrate Tablets.
Read More »
June 3, 2011
Goodwin Biotechnology, Inc. (GBI) and Alethia Biotherapeutics, Inc. have entered a collaboration for the development of a mammalian cell line-based IgG monoclonal antibody project for the treatment of cancer.
Read More »
June 2, 2011
Roche and Bristol-Myers Squibb have entered a collaboration agreement to evaluate BMS’ CTLA-4 inhibitor, YERVOY (ipilimumab), in combination with Roche’s investigational oral BRAF inhibitor, vemurafenib, for the treatment of a specific type of metastatic melanoma.
Read More »
June 1, 2011
PharmaNet Development Group is collaborating with the Cancer Immunotherapy Trials Network (CITN) to help identify trials with immunotherapy agents prioritized by CITN as having high potential for cancer therapy.
Read More »
May 26, 2011
PharmaNet Development Group’s subsidiary, PharmaNet Canada, Inc. and Maisonneuve-Rosemont Hospital (HMR) and its Research Center, have agreed to collaborate in the conduct of pharmacokinetic studies in patients with impaired renal function.
Read More »
May 25, 2011
Sixth milestone resulting from 2005 CNS pact
Read More »
406 - 420 of 1091 results
